CClinicalTrials.gg
CompletedNCT04014686Updated Nov 3, 2020

12 Weeks of Resistance Band Exercise Impacts on Metabolic Syndrome Progression in Postmenopausal Women

An interventional study of No exercise intervention group and Resistance band exercise intervention group in Metabolic Syndrome, Dyslipidemias and Insulin Resistance, sponsored by Pusan National University. Completed at 1 site in United States. Open to female participants. Per ClinicalTrials.gov, last updated 2020-11-03.

Sponsored by Pusan National University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Sex
Female
01

Study summary

The purpose of this study was to examine the impacts of a 12-week resistance band exercise program on insulin resistance, blood lipid profiles, body composition, and blood pressure in postmenopausal women with obesity.

Thirty-six postmenopausal women participated in this study. Participants were randomly allocated into the resistance band training group (EX, n = 18) or the control group (CON, n = 18). The EX group performed a resistance band exercise training program 60 minutes per day, 3 times per week, for 12 weeks. The CON group did not participate in any exercise, dietary, or behavioral intervention. Blood glucose, insulin, homeostatic model of insulin resistance (HOMA-IR), blood lipids, blood pressure, and body composition were measured before and after 12 weeks of EX or CON.

02

Conditions studied

  • Metabolic Syndrome
  • Dyslipidemias
  • Insulin Resistance
  • Hypertension

Keywords

  • postmenopausal
  • exercise
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • postmenopausal (cessation of menses for at least 12 consecutive months)
  • abdominal obesity (waist > 80 cm)

Exclusion criteria

Exclusion Criteria:

  • current smoker (smoking within 6 months of participation)
  • cardiovascular disease
  • renal disease
  • pulmonary disease
  • thyroid disease
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Sham comparator
    Control group

    No exercise intervention

    Other: No exercise intervention group

  • Experimental
    Exercise intervention group

    Exercise intervention group (resistance band exercise training for 12 weeks, 3x per week, for 60 minutes per day).

    Behavioral: Resistance band exercise intervention group

Interventions

  • OtherNo exercise intervention group

    no exercise intervention

  • BehavioralResistance band exercise intervention group

    Resistance band exercise training intervention (12 weeks, 3x per week, for 60 minutes per day)

05

What researchers measure

Primary outcomes

  1. Glucose

    Blood glucose was measured before and after 12 weeks.

    Time frame: 12 weeks

  2. Insulin

    Blood insulin was measured before and after 12 weeks.

    Time frame: 12 weeks

  3. Percentage of Body Fat

    Body fat percentage was measured before and after 12 weeks.

    Time frame: 12 weeks

  4. Waist circumference

    Waist circumference was measured before and after 12 weeks.

    Time frame: 12 weeks

Secondary outcomes

  1. Systolic blood pressure

    Systolic blood pressure was measured before and after 12 weeks.

    Time frame: 12 weeks

  2. Diastolic blood pressure

    Diastolic blood pressure was measured before and after 12 weeks.

    Time frame: 12 weeks

06

Study locations

1 site
  • The University of Nebraska at Omaha
    Omaha, Nebraska 68182, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT04014686
Lead sponsor
Pusan National University
Collaborators
Dong-Eui University, University of Nebraska
Responsible party
Won-mok son (Principal Investigator, Pusan National University) — Principal investigator
First posted
Jul 10, 2019
Start date
Apr 1, 2018
Primary completion
Aug 1, 2018
Completion
Oct 1, 2018
Last update
Nov 3, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion